Ritvij Satodiya is a Psychiatry physician. OpenAlex indexes 28 publications with 219 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13950 Ballantyne Corporate Pl Ste 155
Charlotte, NC 282773163
Telephone
347-670-0033Provider last certified this registry record 15 Oct 2024.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year20253 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic31.7%Quetiapine Fumarate36%Aripiprazole33%Clozapine31%Part D<11 patientsSSRI31%Trazodone Hcl52%Sertraline Hcl48%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence
Current Psychopharmacologye
2024 - 1.72 Exposure to Exogenous Cannabinoids in Prenatal Periods and Early Childhood: Importance of Identifying Critical Windows for Brain Influences
Journal of the American Academy of Child & Adolescent Psychiatry
2023 - 1.21 Cost-Effectiveness and Utilization of Multisystemic Therapy for Conduct Disorder: A Systematic Review
Journal of the American Academy of Child & Adolescent Psychiatry
2023
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”